cromolyn sodium has been researched along with Acute Liver Injury, Drug-Induced in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Edlow, D; Rosenberg, JL; Sneider, R | 1 |
Gholson, CF; Warren, GH | 1 |
3 other study(ies) available for cromolyn sodium and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Liver disease and vasculitis in a patient taking cromolyn.
Topics: Blood Proteins; Chemical and Drug Induced Liver Injury; Cromolyn Sodium; Drug Hypersensitivity; Female; Fluorescent Antibody Technique; Humans; Liver Diseases; Lymphocyte Activation; Middle Aged; Protein Binding; Skin; Vasculitis | 1978 |
Fulminant hepatic failure associated with intravenous erythromycin lactobionate.
Topics: Aged; Anemia, Hemolytic; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Erythromycin; Humans; Male; Respiratory Tract Infections | 1990 |